EUVIMEDEUVIMED entdecken
Crossref

Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction

Ahmed A Gaber, Ayman Abo Elmaaty, Marwa Sharaky, Aliaa A Mosa, Abdullah Yahya Abdullah Alzahrani, Saad Shaaban, Wagdy M Eldehna, Ahmed A Al-Karmalawy

Bioorganic Chemistry · 2024

DOI: 10.1016/j.bioorg.2024.107223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024. Verfasst von Ahmed A Gaber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents, Biphenyl Compounds. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we envisioned the design and synthesis of novel pyrazolopyrimidines (confirmed by elemental analysis, 1H and 13C NMR, and mass spectra) as multitarget-directed drug candidates acting as EGFR/TOPO II inhibitors, DNA intercalators, and apoptosis inducers. The target diphenyl-tethered pyrazolopyrimidines were synthesized starting from the reaction of phenyl hydrazine and ethoxymethylenemalononitrile to give aminopyrazole-carbonitrile 2. The latter hydrolysis with NaOH and subsequent reaction with 4-chlorobenzaldhyde afforded the corresponding pyrazolo[3,4-d]pyrimidin-4-ol 4. Chlorination of 4 with POCl3 and sequential reaction with different amines afforded the target compounds in good yields (up to 73 %). The growth inhibition % of the new derivatives (6a-m) was investigated against different cancer and normal cells and the IC50 values of the most promising candidates were estimated for HNO97, MDA-MB-468, FaDu, and HeLa cancer cells. The frontier derivatives (6a, 6i, 6k, 6l, and 6m) were pursued for their EGFR inhibitory activity. Compound 6l decreased EGFR protein concentration by a 6.10-fold change, compared to imatinib as a reference standard. On the other side, compounds (6a, 6i, 6k, 6l, and 6m) underwent topoisomerase II (TOPO II) inhibitory assay. In particular, compounds 6a and 6l exhibited IC50s of 17.89 and 19.39 μM, respectively, surpassing etoposide with IC50 of 20.82 μM. Besides, the DNA fragmentation images described the great potential of both candidates 6a and 6l in inducing DNA degradation at lower concentrations compared to etoposide and doxorubicin. Moreover, compound 6l, with the most promising EGFR/TOPO II inhibition and DNA intercalation, was selected for further investigation for its apoptosis induction ability by measuring caspases 3, 7, 8, and 9, Bax, p53, MMP2, MMP9, and BCL-2 proteins. Additionally, molecular docking was used to explain the SAR results based on the differences in the molecular features of the investigated congeners and the target receptors' topology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBiphenyl CompoundsHumansMolecular StructureStructure-Activity RelationshipMolecular Docking SimulationEtoposideDNA Topoisomerases, Type IICell ProliferationTopoisomerase II InhibitorsApoptosisErbB ReceptorsDNADrug Screening Assays, Antitumor

Stichwörter der Autor:innen

ApoptosisDNA intercalationEGFRMulti-target rationalePyrazolopyrimidineTOPO II

Substanzen

Antineoplastic AgentsEtoposideDNA Topoisomerases, Type IITopoisomerase II InhibitorsErbB ReceptorsDNABiphenyl CompoundsbiphenylEGFR protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt.
  • Cancer Biology Department, Pharmacology Unit, National Cancer Institute (NCI), Cairo University, Cairo, Egypt; Biochemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Giza 12566, Eg…
  • Department of Medical Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Department of Chemistry, Faculty of Science and Arts, King Khalid University, Mohail Assir, Saudi Arabia.
  • Department of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia; Department of Chemistry, Faculty of Science, Mansoura University, 35516 Mansoura, Egypt.

Förderung

  • Deanship of Scientific Research, King Khalid University

Zitieren

APA

Gaber, A. A., Abo Elmaaty, A., Sharaky, M., Mosa, A. A., Yahya Abdullah Alzahrani, A., Shaaban, S., Eldehna, W. M., & Al-Karmalawy, A. A. (2024). Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2024.107223

Vancouver

Gaber AA, Abo Elmaaty A, Sharaky M, Mosa AA, Yahya Abdullah Alzahrani A, Shaaban S, et al. Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction. Bioorganic Chemistry. 2024. doi:10.1016/j.bioorg.2024.107223

BibTeX
@article{Gaber2024,
  author = {Gaber, Ahmed A and Abo Elmaaty, Ayman and Sharaky, Marwa and Mosa, Aliaa A and Yahya Abdullah Alzahrani, Abdullah and Shaaban, Saad and Eldehna, Wagdy M and Al-Karmalawy, Ahmed A},
  title = {Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction},
  journal = {Bioorganic Chemistry},
  year = {2024},
  doi = {10.1016/j.bioorg.2024.107223}
}
Kostenlos starten →